• 1
    Rubin I,Yarden Y. The basic biology of HER2. Ann Oncol. 2001; 2: 38.
  • 2
    Slamon DJ,Godolphin W,Jones LA, et al. Studies of the HER2/neu proto-oncogene in human breast and ovarian cancer. Science. 1989; 224: 701712.
  • 3
    Leyland-Jones B. Trastuzumab: hopes and realities. Lancet Oncol. 2002; 3: 187144.
  • 4
    Thor A. HER-2. A discussion of testing approaches in the USA. Ann Oncol. 2001; 12: 101107.
  • 5
    Bofin AM,Ytterhus B,Martin C,O'Leary JJ,Hagmar BM. Detection and quantitation of HER-2 gene amplification and protein expression in breast carcinoma. Am J Clin Pathol. 2004; 122: 110119.
  • 6
    Nizzoli R,Bozzetti C,Crafa P, et al. Immunocytochemical evaluation of HER-2/neu on fine-needle aspirates from primary breast carcinomas. Diagn Cytopathol. 2003; 28: 142146.
  • 7
    Mezzelani A,Alasio L,Bartoli C, et al. c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates. Br J Cancer. 1999; 80: 519525.
  • 8
    Patterson AH,McMamus DT,Maxwell P. Detection of chromosomal numerical abnormalities in clinical breast tumor fine-needle aspirations by fluorescence in situ hybridization (FISH): requirement of a method. Br J Biomed Sci. 1998; 55: 27.
  • 9
    Sneige N,Liu B,Yin G,Gong Y,Arun BK. Correlation of cytologic findings and chromosomal instability detected by fluorescence in situ hybridization in breast fine-needle aspiration specimens from women at high risk for breast cancer. Mod Pathol. 2006; 19: 622629.
  • 10
    Tsukamoto F,Miyoshi Y,Koyama H, et al. Detection of chromosomal aneusomy by fluorescence in situ hybridization in fine-needle aspirates from breast tumors: application to the preoperative diagnosis of breast carcinoma. Cancer (Cancer Cytopathol). 2000; 90: 373378.
  • 11
    Magda JL,Minger BA,Rimm DL. Polymerase chain reaction-based detection of clonality as a non-morphologic diagnostic tool for fine-needle aspirations of the breast. Cancer (Cancer Cytopathol). 1998; 84: 262267.
  • 12
    Euhus DM,Maitra A,Wistuba II. Use of archival fine-needle aspirates for the allelotyping of tumors. Cancer (Cancer Cytopathol). 1999; 87: 372379.
  • 13
    Pu RT,Laitala LE,Alli PM,Fackler MJ,Sukumar S,Clark DP. Methylation profiling of benign and malignant breast lesions and its application to cytopathology. Mod Pathol. 2003; 16: 10951101.
  • 14
    Geaonimo C,Costa J,Martins MC, et al. Detection of gene promoter hypermethylation in fine needle washing from breast lesions. Clin Cancer Res. 2003; 9: 34133417.
  • 15
    Assersohn L,Gangi L,Zhao Y, et al. The feasibility of using fine needle aspiration from primary breast cancers for CDNA microarray analysis. Clin Cancer Res. 2002; 8: 794801.
  • 16
    Symmans WF,Pusztai L,Ayers M, et al. RNA yield from needle biopsies for cDNA microarray analysis of breast cancer prior to neoadjuvant chemotherapy. Cancer. 2003; 97: 29602971.
  • 17
    Pusztai L,Ayers M,Stec J. Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors. Clin Cancer Res. 2003; 9: 24062415.
  • 18
    Ayers M,Symmans WF,Stec J, et al. Gene expression profiling of fine needle aspirations of breast cancer identifies genes associated with complete pathologic response to neoadjuvant. Taxol/FAC chemotherapy. J Clin Oncol. 2004; 22: 22842293.
  • 19
    Sotiriou C,Powles J,Dowsett M, et al. Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer. Breast Cancer Res. 2002; 4: R3.
  • 20
    Dei Tos AP,Dal Cin P. The role of cytogenetics in the classification of soft tissue tumors. Virchows Arch. 1997; 431: 8394.
  • 21
    Nilbert M. Molecular and cytogenetics of soft tissue sarcomas. Acta Orthoph Scand. 1997; 68: 6067.
  • 22
    Fletcher CD. Soft tissue tumors. The impact of cytogenetics and molecular genetics. Verh Dtsch Cres Pathol. 1997; 81: 318326.
  • 23
    Saboorian MH,Ashfaq R,Vardersteenhoven TJ, et al. Cytogenetics as an adjunct in establishing a definitive diagnosis of synovial sarcoma by fine needle aspiration. Cancer (Cancer Cytopathol). 1997; 81: 187192.
  • 24
    Hummel P,Yang GCH,Kumar A, et al. PNET-like features of synovial sarcoma of the lung: a pitfall in the cytologic diagnosis of soft-tissue tumors. Diagn Cytopathol. 2001; 24: 283288.
  • 25
    Sapi Z,Antal I,Papai Z, et al. Diagnosis of soft tissue tumors by fine-needle aspiration with combined cytopathology and ancillary techniques. Diagn Cytopathol. 2002; 26: 232242.
  • 26
    Ferlicot S,Coue O,Gilbert E. et al. Intra-abdominal desmoplastic small round cell tumor. Report of a case with fine needle aspiration, cytologic diagnosis and molecular confirmation. Acta Cytol. 2001; 45: 617621.
  • 27
    Frostad B,Martinsson T,Tani E, et al. The use of fine-needle aspiration cytology in the molecular characterization of neuroblastoma in children. Cancer (Cancer Cytopathol). 1999; 87: 6068.
  • 28
    Letcher CD,Bermar JJ,Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002; 33: 459465.
  • 29
    Demetri GD,von Mehron M,Blarke CD, et al. Efficacy and safety imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 2002; 347: 472480.
  • 30
    Willmore-Payne C,Layfield LJ,Holden JA. c-KIT mutation analysis for diagnosis of gastrointestinal stromal tumors in fine needle aspiration specimens. Cancer (Cancer Cytopathol). 2005; 105: 165170.
  • 31
    Dong HY,Harris NL,Pfeffer FI, et al. Fine-needle aspiration biopsy in the diagnosis and classification of primary and recurrent lymphoma: a retrospective analysis of the utility of cytomorphology and flow cytometry. Mod Pathol. 2001; 14: 472481.
  • 32
    Young NA,Al-Saleem TI,Ehya H, et al. Utilisation of fine needle aspiration cytology and flow cytometry in the diagnosis and sub classification of primary and recurrent lymphoma. Cancer (Cancer Cytopathol). 1998; 84: 252261.
  • 33
    Nicol TL,Silberman M,Rosenthal DL, et al. The accuracy of combined cytopathologic and flow cytometric analysis of fine-needle aspirates of lymph nodes. Am J Clin Pathol. 2000; 114: 1828.
  • 34
    Liu K,Stern RC,Rogers RT, et al. Diagnosis of hematopoietic processes by fine-needle aspiration in conjunction with flow cytometry: A review of 127 cases. Diagn Cytopathol. 2001; 24: 110.
  • 35
    Meda BA,Buss DH,Woodruff RD, et al. Diagnosis and sub classifications of primary and recurrent lymphoma: the usefulness and limitations of combined fine-needle aspiration cytomorphology and flow cytometry. Am J Clin Pathol. 2000; 113: 688699.
  • 36
    Sigstad E,Dong HP,Davidson B, et al. The role of flow cytometric immunophenotyping in improving the diagnostic accuracy in fine-needle aspiration specimens. Diagn Cytopathol. 2004; 31: 159163.
  • 37
    Williams ME,Frierson HFJr,Tabbarah S,Ennis PS. Fine-needle aspiration of non-Hodgkin's lymphoma: Southern blot analysis for antigen receptor, bcl-2, and c-myc gene rearrangements. Am J Clin Pathol. 1990; 93: 754759.
  • 38
    Hu E,Horning S,Flynn S,Brown S,Warnke R,Sklar J. Diagnosis of B cell lymphoma by analysis of immunoglobulin gene rearrangements in biopsy specimens obtained by fine needle aspiration. J Clin Oncol. 1986; 4: 278283.
  • 39
    Katz RL,Hirsch-Ginsberg C,Childs C, et al. The role of gene rearrangements for antigen receptors in the diagnosis of lymphoma obtained by fine-needle aspiration: a study of 63 cases with concomitant immunophenotyping. Am J Clin Pathol. 1991; 96: 479490.
  • 40
    Jeffers MD,McCorriston J,Farquharson MA,Stewart CJ,Mutch AF. Analysis of clonality in cytologic material using the polymerase chain reaction (PCR). Cytopathology. 1997; 8: 114121.
  • 41
    Vianello F,Tison T,Radossi P, et al. Detection of B-cell monoclonality in fine needle aspiration by PCR analysis. Leuk Lymphoma. 1998; 29: 179185.
  • 42
    Kikuchi M,Kitamura K,Nishio Y, et al. Diagnosis of B-cell lymphoma: utility of the polymerase chain reaction for detecting clonality from archival cytologic smears. Acta Cytol. 2002; 46: 349356
  • 43
    Maroto A,Rodriguez-Peralto JL,Martinez MA,Martinez M,de Augustin P. A single primer pair immunoglobulin polymerase chain reaction assay as a useful tool in fine-needle aspiration biopsy differential diagnosis of lymphoid malignancies. Cancer (Cancer Cytopathol). 2003; 99: 180185.
  • 44
    Stewart CJR,Duncan JA,Farquharson M,Richmond J. Fine needle aspiration cytology diagnosis of malignant lymphoma and reactive lymphoid hyperplasia. J Clin Pathol. 1998; 51: 197203.
  • 45
    Safley AM,Buckley PJ,Creager AJ, et al. The value of fluorescence in situ hybridization and polymerase chain reaction in the diagnosis of B-cell non-Hodgkin lymphoma by fine-needle aspiration. Arch Pathol Lab Med. 2004; 128: 13951403.
  • 46
    Venkatraman L,Catherwood MA,Patterson A,Tong LF,McCluggage W,Anderson NH. The role of PCR and immunocytochemistry in cytological assessment of lymphoid proliferations. J Clin Pathol. 2006
  • 47
    Alkan S,Lehman C,Sarago C,Sidawy MK,Karchers DS,Garrett CT. Polymerase chain reaction detection of immunoglobulin gene rearrangement and bcl-2 translocation in archival glass slides of cytologic material. Diagn Mol Pathol. 1995; 4: 2531.
  • 48
    Aiello A,Delia D,Giardini R, et al. PCR analysis of IgH and bc12 gene rearrangement in the diagnosis of follicular lymphoma in lymph node fine-needle aspiration. A critical appraisal. Diagn Mol Pathol. 1997; 6: 154160.
  • 49
    Bentz JS,Rowe LR,Anderson SR,Gupta PK,McGrath CM. Rapid detection of the t(11;14) translocation in mantle cell lymphoma by interphase fluorescence in situ hybridization on archival cytopathological material. Cancer (Cancer Cytopathol). 2004; 102: 124131.
  • 50
    Hughes JH,Caraway NP,Katz RL. Blastic variant of mantle-cell lymphoma: cytomorphologic, immunocytochemical, and molecular genetic features of issue obtained by fine-needle aspiration biopsy. Diagn Cytopathol. 1998; 19: 5962.
  • 51
    Caraway NP,Gu J,Lin P,Romaguera JE,Glassman A,Katz R. The utility of interphase fluorescence in situ hybridization for the detection of the translocation t(11;14)(q13;q32) in the diagnosis of mantle cell lymphoma on fine-needle aspiration specimens. Cancer (Cancer Cytopathol). 2005; 105: 110118.
  • 52
    Shin HJ,Thorson P,Gu J,Katz RL. Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization. Diagn Cytopathol. 2003; 29: 6166.
  • 53
    Shivnarain D,Ladanyi M,Zakowski MF. Detection of BCL2 rearrangement in archival cytological smears of B-cell lymphomas. Mod Pathol. 1994; 7: 915919
  • 54
    Gong Y,Caraway N,Gu J, et al. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping. Cancer (Cancer Cytopathol). 2003; 99: 38593.
  • 55
    Goy A,Stewart J,Barkoh BA, et al. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma. Cancer (Cancer Cytopathol). 2006; 108: 1020.
  • 56
    Gharib H,Goellner JR. Fine needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med. 1993; 118; 282289.
  • 57
    Jhiang SM,Mazzaferri EL. The ret/PTC oncogene in papillary thyroid carcinoma. J Lab Clin Med. 1994; 123: 331337.
  • 58
    Santoro M,Carlomagno F,Hay ID, et al. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest. 1992; 89: 15171522.
  • 59
    Cheung CC,Carydis B,Ezzat S,Bedard YC,Asa SL. Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer. J Clin Endocrinol Metab. 2006; 86: 21872190.
  • 60
    Cohen Y,Xing M,Mambo E, et al. BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst. 2003; 95: 625627.
  • 61
    Cohen Y,Rosenbaum E,Clark DP, et al. Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: A potential application for the preoperative assessment of thyroid nodules. Clin Cancer Res. 2004; 10: 27612765.
  • 62
    Rowe LR,Bentz BG,Bentz JS. Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules. Cytojournal. 2006; 3: 10.
  • 63
    Rhyu MS. Telomeres, telomerase and immortality. J Natl Cancer Inst. 1995; 87: 884894
  • 64
    Umbricht CB,Conrad GT,Clark DP, et al. Human telomerase reverse transcriptase gene expression and the surgical management of suspicious thyroid tumors. Clin Cancer Res. 2004; 10: 57625768.
  • 65
    Siddiqui MT,Greene KL,Clark DP, et al. Human telomerase reverse transcriptase expression in Diff-Quik stained FNA samples from thyroid nodules. Diagn Mol Pathol. 2001; 10: 123129.
  • 66
    Mora J,Lerma E.Thyroid Neoplasia Study Group. Telomerase activity in thyroid fine needle aspirates. Acta Cytol. 2004; 48: 818824.
  • 67
    Kebebew E,Peng M,Reiff E,Targ O,Clark OH,McMillan A. ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. Ann Surg. 2005; 242: 353361
  • 68
    Kebebew E,Peng M,Reiff E,McMillan A. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms. Cancer. 2006; 106: 25922597.
  • 69
    Salazar AM,Westcott JL. The role of transthoracic biopsy for the diagnosis and staging of lung cancer. Clin Chest Med. 1993; 14: 99110.
  • 70
    Savic S,Glatz K,Schoenegg R, et al. Multitarget fluorescence in situ hybridization elucidates equivocal lung cytology. Chest. 2006; 129: 16291635.
  • 71
    Warner KA,Crawford EL,Zaher A, et al. The c-myc x E2F-1/p21 interactive gene expression widen augments cytomorphologic diagnosis of lung cancer in fine needle aspirate specimens. J Mol Diagn. 2003; 5: 176183.
  • 72
    Lynch TJ,Bell DW,Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small cell lung cancer to gefitinib. N Engl J Med. 2004; 350: 21292139.
  • 73
    Takaro T,Ohe J,Sakamoto H, et al. Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small cell lung cancer. J Clin Oncol. 2005; 23: 68296837.
  • 74
    Hirsch FR,Varella-Garcia M,McCoy J, et al. Increased EGFR gene copy numbers detected by FISH associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes. A southwest oncology group study. J Clin Oncol. 2005; 23: 68386845.
  • 75
    Johnson BE,Janne PA. Selecting patients for epidermal growth factor receptor inhibitor treatment: a FISH story or a tale of mutations. J Clin Oncol. 2005; 1: 68136816.
  • 76
    Lim EH,Aggarwal A,Agasthian T, et al. Feasibility of using low-volume tissue samples for gene expression profiling of advanced non-small cell lung cancers. Clin Cancer Res. 2003; 9: 59805987.
  • 77
    Pellise M,Castells A,Gines A, et al. Detection of lymph node micrometastases by gene promoter hypermethylation in samples obtained by endosonography-guided fine-needle aspiration biopsy. Clin Cancer Res. 2004; 10: 44444449.
  • 78
    Wallace MB,Block M,Hoffman BJ, et al. Detection of telomerase expression in mediastinal lymph nodes of patients with lung cancer. Am J Resp Crit Care Med. 2003; 167: 16701675.
  • 79
    Wallace MB,Block MI,Gillanders W, et al. Accurate molecular detection of non-small cell lung cancer metastases in mediastinal lymph nodes sampled by endoscopic ultrasound-guided needle aspiration. Chest. 2005; 127: 430437.
  • 80
    Myo K.Uzawa N,Miyamoto R,Sonota I,Yuki Y,Amagasa T. Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM stage 1 an 11 squamous cell carcinoma of the dial oral cavity. Cancer. 2005; 104: 27092716.
  • 81
    Voit C,Schoengen A,Schwurzer M,Weber L,Mayer T,Proebstle TM. Detection of regional melanoma metastases by ultrasound B-scan, cytology or tyrosinase RT-PCR of fine-needle aspirates. Br J Cancer. 80: 1999; 16721677.
  • 82
    Eloubeidi MA,Jhala D,Chhieng DC, et al. Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma. Cancer (Cancer Cytopathol). 2003; 99: 285292.
  • 83
    Evans DB,Frazier ML,Charnsangavej C. Molecular diagnosis of exocrine pancreatic cancer using a percutaneous technique. Ann Surg Oncol. 1996; 3: 241246.
  • 84
    Tada M,Komatsu Y,Kawabe T, et al. Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonograpy-guided fine-needle aspiration. Clinical utility for diagnosis of pancreatic tumor. Am J Gastroentrol. 2002; 97: 22632270.
    Direct Link:
  • 85
    Van Heek T,Raden AE,Offerhaus JA, et al. K-ras, p53, and DPC4 (MAD4) alterations in fine-needle aspirates of the pancreas. A molecular panel correlates with and supplements cytologic diagnosis. Am J Clin Pathol. 2002; 117: 755765.
  • 86
    Talar-Wajnarowska R,Gasiorowska A,Smolarz B, et al. Clinical significance of K-ras and c-erbB-2 mutations in pancreatic adenocarcinoma and chronic pancreatitis. Int J Gastrointest Cancer. 2005; 35: 3342.
  • 87
    Mishra G,Zhao Y,Sweeney J, et al. Determination of qualitative telomerase activity as an adjunct to the diagnosis of pancreatic adenocarcinoma by EUS-guided fine-needle aspiration. Gastrointest Endosc. 2006; 63: 648654.
  • 88
    Kitoh H,Ryozawa S,Harada T, et. Comparative genomic hybridization analysis for pancreatic cancer specimens obtained by endoscopic ultrasonography guided fine-needle aspiration. J Gastroenterol. 2005; 40: 511517.
  • 89
    Laurell H,Bouisson M,Berthelemy P, et. Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples. World J Gastroenterol. 2006; 12: 33443351.
  • 90
    Li G,Cuilleron M,Cottier M, et al. The use of MN/CA9 gene expression in identifying malignant solid renal tumors. Eur Urol. 2006; 49: 401405.
  • 91
    Pastorek J,Pastorekkova S,Callbaut I, et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and putative helix-loop-helix DNA binding segment. Oncogene. 1994; 9: 28772887.
  • 92
    Li G,Culleron M,Genlil-Perret, et al. Rapid and sensitive detection of messenger RNA expression for molecular differential diagnosis of renal cell. Carcinoma. 2003; 9: 64416446.
  • 93
    Li P,Perle MA,Scholes JV,Tang GCH. Wilms' tumor in adults: aspiration cytology and cytogenetics. Diagn Cytopathol. 2001; 26: 99103.
  • 94
    Al-Khafaji BM,Pasco-Miller LA,Zhang HZ,Katz RL. Chromosomal aberrations in renal cell carcinoma: a diagnostic and prognostic role for cytopathology. Acta Cytol. 1998; 42: 1217.
  • 95
    Bruijnesteijn Van Coppenraet ES,Lindeboom JA,Prins JM,Peeters MF,Claas ECJ,Kuijper EJ. Real-time PCR assay using fine-needle aspirates and tissue biopsy specimens for rapid diagnosis of mycobacterial lymphadenitis in children. J Clin Microbiol. 2004; 42: 26442650
  • 96
    Aljafari AS,Khalis EAG,Elsiddig KE, et al. Diagnosis of tuberculous lymphaderitis by FNAC, microbiological methods and PCR: a comparative study. Cytopathology. 2004; 15: 4448.
  • 97
    Gong G,Lee H,Kang GH,Shin J,Huh J,Khang SK. Nested PCR for diagnosis of tuberculous lymphadenitis and PCR-SSP for identification of rifampicin resistance in fine needle aspirates. Diagn Cytopathol. 2001; 26: 228231.
  • 98
    Avidor B,Varon M,Marmor S, et al. DNA amplification for the diagnosis of cat-scratch disease in small-quantity clinical specimens. Am J Clin Pathol. 2001; 15: 900909.
  • 99
    Starac D,Brestovac B,Sterrett GF,Smith DW,Frost FA. Can HPV DNA testing on FNA material determine anogenital origin in metastatic squamous cell carcinoma? Pathology. 2005; 37: 197203.